AstraZeneca (AZN) Gets a Hold from Deutsche Bank
Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on AstraZeneca (AZN – Research Report) today and set a price target of ...
U.S. News & World Report18 天
AstraZeneca Investing $2.5 Billion in China as Drugmaker Seeks to Recover From Scandals
LONDON (Reuters) - AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market ...